ophthalmology

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The non-invasive eye examination is also used to identify conditions such as diabetic neuropathy, Parkinson’s disease, multiple sclerosis, and dementia. 

Funding will be used to push for regulatory approval of its flagship synthetic implant product. 

Pr3vent's non-invasive tool looks to catch ophthalmic conditions when kids are still young.

Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials.

The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.

 In new study published in Ophthalmology,  Google AI researchers found that they could improve their AI disease detecting software by using a small subset of images adjudicated by ophthalmologists that specialize in retinal diseases.